Wilson Sonsini Goodrich & Rosati represented Temasek on U.S. matters in the transaction Tessa Therapeutics, an international biopharmaceutical company focused on T-cell therapy for solid tumors,…
Tessa Therapeutics’ $80 Million Financing Round
Wilson Sonsini Goodrich & Rosati represented Temasek on U.S. matters in the transaction Tessa Therapeutics, an international biopharmaceutical company focused on T-cell therapy for solid tumors,…